探索HAPC在COVID-19引起的急性肺损伤中的治疗潜力

Zhichen Pu1, Lingling Li2, Yan Zhang3

  • 1Anhui Province Key Laboratory of Non-coding RNA Basic and Clinical Transformation, Wuhu, Anhui 241001, China,; Drug Clinical Evaluation, The First Affiliated Hospital of Wannan Medical College (Yijishan Hospital of Wannan Medical College), Wuhu, Anhui 241001, China.

概括

这项研究开发了一种新型纳米复合物 (HAPC),用于治疗COVID-19引起的急性肺损伤 (ALI). HAPC通过调节关键的炎症途径,有效地准ALI,提供了潜在的新治疗策略.